Saratoga Health & Biotechnology Fund
Filed by Saratoga Advantage Trust. What this fund reported holding in its latest quarterly NPORT-P. Positions are ordered by share of the fund rather than by size, because that is what separates a conviction from a rounding error.
What it holds
Largest share of the fund first.
| Company | % of fund | Value |
|---|---|---|
| AMGNAmgen Inc | 5.83% | $673.6K |
| MCKMcKesson Corp | 5.29% | $611.8K |
| CAHCardinal Health Inc | 5.14% | $593.4K |
| UTHRUnited Therapeutics Corp | 5.12% | $592K |
| CORCencora Inc | 4.71% | $544.6K |
| REGNRegeneron Pharmaceuticals Inc | 4.63% | $535.4K |
| EXELExelixis Inc | 4.47% | $516.1K |
| JNJJohnson & Johnson | 4.19% | $483.8K |
| NVSNovartis AG | 4.13% | $477.5K |
| MRKMerck & Co Inc | 4.10% | $473.7K |
| MEDPMedpace Holdings Inc | 4.06% | $469.3K |
| GILDGilead Sciences, Inc | 3.89% | $449K |
| VRTXVertex Pharmaceuticals Inc | 3.71% | $428.5K |
| INCYIncyte Corp | 3.34% | $385.9K |
| CICigna Group | 3.28% | $378.5K |
| BMYBristol-Myers Squibb Co | 3.26% | $376.1K |
| ISRGIntuitive Surgical Inc | 2.53% | $292.1K |
| LHLabcorp Holdings Inc | 2.44% | $282.4K |
| SYKStryker Corp | 2.31% | $267.1K |
| LNTHLantheus Holdings Inc | 2.18% | $252.4K |
| NBIXNeurocrine Biosciences Inc | 2.01% | $232.4K |
| LLYEli Lilly and Co | 2.00% | $231.3K |
| ELVElevance Health Inc | 1.47% | $170K |
| NVONovo Nordisk A/S | 1.40% | $161.4K |
Source: NPORT-P filings, via EDGAR. Positions arrive by CUSIP, and only a CUSIP verified against a ticker is kept — so this is what we could match, not everything the fund holds, and the matched value is therefore below the fund's own size. A balance is shares where the filing says `NS` and a principal amount where it says `PA`, which is why it is not labelled shares in both cases.
Follow Saratoga Health & Biotechnology Fund by email
Saratoga Health & Biotechnology Fund's new holdings reports, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.